Form 4 for WST West Pharmaceutical Services
Accepted 2026-02-19 00:00:00 ET · period of report 2026-02-17 · accession 0000105770-26-000019 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 | 2026-02-17 | WST | Witherspoon Charles | VP, Treas | F - Tax | $243.19 | -41.52 | 1,370 | -3% | -$10.1K | |
| 2026-02-19 | 2026-02-17 | WST | Witherspoon Charles | VP, Treas | A - Grant | $0.00 | +115.91 | 1,411 | +9% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-17 | F | D | 41.52 | $243.19 | 1,369.75 | D | — | — | |
| 2 | Common | Common Stock | 2026-02-17 | A | A | 115.91 | $0.00 | 1,411.27 | D | — | — | (F1) These shares result from performance stock units (PSUs) which vested at the end of the respective 2023-2025 PSU performance period and were payable on the transaction date shown. |